Search
18. Miscellaneous (non-BNF and unlicensed drugs)
Acetic Acid Solution 3%
BNF | BNFC | SPC

Endoscopy use

ACID CITRATE DEXTROSE 750ml
BNF | BNFC | SPC

For cell salvage

Alkaline Nasal Douche
BNF | BNFC | SPC
ASPIRIN 500mg/5ml
BNF | BNFC | SPC

Cardiology only

Baclofen Intrathecal
BNF | BNFC | SPC

Use by specialist only

Bisacodyl 0.274% rectal soln
BNF | BNFC | SPC

Used in spinal injuries only

Carbex granules
BNF | BNFC | SPC
Cardioplegia Solution
BNF | BNFC | SPC

Cardiology only

CARNOY'S soln 100ml
BNF | BNFC | SPC
Clonidine Intrathecal Injection
BNF | BNFC | SPC

Specialist use only

Co-Careldopa liquid
BNF | BNFC | SPC

Paediatrics only

CODEINE PHOSPHATE Suppositories
BNF | BNFC | SPC

15 mg,2mg,3mg,6mg Suppositories
Restricted Paediatrics only

Diphencyprone in acetone
BNF | BNFC | SPC

Unlicensed product
Various strengths available. Not routinely stocked at STHFT ordered asd needed.
Dermatology use in alopecia only

FERRIC SUBSULPHATE (monsel's soln) 50ml
BNF | BNFC | SPC

50ml

Glycopyrrolate 0.5% in Cetomacrogol A
BNF | BNFC | SPC

For use by endocrinology for gustatory sweating or dermatology for hyperhidrosis
Due to short expiry ordered as required

INDIGO CARMINE Injection 0.8 %
BNF | BNFC | SPC
Iopamidol (Niopam®)
BNF | BNFC | SPC
LAT Gel
BNF | BNFC | SPC

Lidocaine 4% Adrenaline 0.1% Tetracaine0.5% gel

For use by ENT only for facial alceration or grommet insertion

Magnesium sulphate 10% solution for injection pre-filled syringe
BNF | BNFC | SPC

For pre-eclampsia, eclampsia and pre-term labour

Mercaptamine HCL (Cysteamine) Eye Drops
BNF | BNFC | SPC

For use in cystinosis on specialist advice only

NexoBrid gel (NexoBrid®)
BNF | BNFC | SPC

For the removal of eschar in adults with deep partial and full thickness thermal burns to a maximum of 15% TBSA.

Phenazopyridine tablets
BNF | BNFC | SPC
Phenol (aqueous) Injection 6%
BNF | BNFC | SPC
Stanozolol 2mg tabs
BNF | BNFC | SPC
Sucrose 24% (Sweat-Ease®)
BNF | BNFC | SPC

Neonatal use only

Talc BP purified sterile
BNF | BNFC | SPC

For use in pleurodesis only

Remdesivir
BNF | BNFC | SPC

Remdesivir 100 mg concentrate for solution for infusion (each vial contains 100 mg of remdesivir, each mL of concentrate contains 5 mg of remdesivir).
Remdesivir 100 mg powder for concentrate for solution for infusion (each vial contains 100 mg of remdesivir, after reconstitution, each vial contains 5 mg/mL of remdesivir solution).

Unlicensed medicine - named patient use only

Following confirmation of a Conditional Marketing Authorisation (CMA) by the European Medicines Agency (EMA) for the use of remdesivir in the treatment of COVID-19, the scientific opinion given for remdesivir via the Early Access to Medicines Scheme (EAMS) put in place on 26th May 2020 has now lapsed.

From 3 July 2020, an interim clinical commissioning policy has been put in place to define routine access to remdesivir in the treatment of COVID-19 across the UK. The policy reflects the conditions of the CMA, but also includes secondary criteria to be used should there be limitations in the supply of remdesivir in the UK.

Further information can be found in the attached alert; the interim clinical commissioning policy is also attached: https://www.cas.mhra.gov.uk/ViewandAcknowledgment/ViewAlert.aspx?AlertID=103063

Commissioner = CCG, tariff included.